| pubmed-article:1770152 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1770152 | lifeskim:mentions | umls-concept:C0029921 | lld:lifeskim |
| pubmed-article:1770152 | lifeskim:mentions | umls-concept:C0681867 | lld:lifeskim |
| pubmed-article:1770152 | lifeskim:mentions | umls-concept:C0002333 | lld:lifeskim |
| pubmed-article:1770152 | lifeskim:mentions | umls-concept:C0033497 | lld:lifeskim |
| pubmed-article:1770152 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:1770152 | pubmed:dateCreated | 1992-2-24 | lld:pubmed |
| pubmed-article:1770152 | pubmed:abstractText | We studied the efficacy of propranolol (Inderal) compared to alprazolam (Xanax) in 29 patients with a diagnosis of agoraphobia with panic disorder or panic disorder with or without limited phobic avoidance in a 6-week double-blind controlled experiment. Alprazolam is effective in those syndromes, whereas to date only negative or ambiguous results had been reported for propranolol. Fourteen patients received a mean daily dose of 5.0 +/- 2.3 mg of alprazolam and 15 patients received 182.0 +/- 60.5 mg mean daily dose of propranolol. We found both drugs to be effective to suppress panic attacks and reduce avoidance behavior. The only significant between-drug difference was a more rapid onset of alprazolam's panicolytic effect. Propranolol merits further study. We suggest patients worthy of a clinical trial. | lld:pubmed |
| pubmed-article:1770152 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1770152 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1770152 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1770152 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1770152 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1770152 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1770152 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1770152 | pubmed:issn | 0271-0749 | lld:pubmed |
| pubmed-article:1770152 | pubmed:author | pubmed-author:FriedmanM JMJ | lld:pubmed |
| pubmed-article:1770152 | pubmed:author | pubmed-author:RavarisC LCL | lld:pubmed |
| pubmed-article:1770152 | pubmed:author | pubmed-author:McHugoG JGJ | lld:pubmed |
| pubmed-article:1770152 | pubmed:author | pubmed-author:HauriP JPJ | lld:pubmed |
| pubmed-article:1770152 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1770152 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:1770152 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1770152 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1770152 | pubmed:pagination | 344-50 | lld:pubmed |
| pubmed-article:1770152 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:meshHeading | pubmed-meshheading:1770152-... | lld:pubmed |
| pubmed-article:1770152 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1770152 | pubmed:articleTitle | A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. | lld:pubmed |
| pubmed-article:1770152 | pubmed:affiliation | Department of Psychiatry, Dartmouth Medical School, Hanover, New Hampshire. | lld:pubmed |
| pubmed-article:1770152 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1770152 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1770152 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1770152 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:1770152 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1770152 | lld:pubmed |
